Comprehensive research using apelin-knockout mice has shown it to induce hyperinsulinemia and insulin resistance [54,55], while studies using apelin treatment mice have shown beneficial functions in obesity and insulin resistance, indicating that apelin could serve as a therapeutic target for treating obesity and related diseases [56,57]. This evidence concerns the gene APLN and Insulin resistance.